SunFire Biotechnologies

SunFire Biotechnologies, founded by Dr. Moon Nahm, is a contract research organization focused on vaccine evaluation. The company's core mission is to support the development of vaccines through advanced immunological assays. Specializing in pneumococcal testing services and antibodies, SunFire Biotechnologies leverages proprietary technologies such as the WHO ELISA for antibodies against pneumococcal capsule and MOPA, which they invented. Their market focus includes pharmaceutical companies and research institutions involved in vaccine development.

Dr. Moon Nahm, a notable figure in immunology, leads the company, bringing significant expertise and innovation to the field. SunFire Biotechnologies has achieved recognition for its pioneering work in pneumococcal testing and antibody development. Their contributions have had a substantial impact on vaccine research, providing critical support to organizations aiming to combat infectious diseases. The company's advancements in immunological assays have positioned them as a key player in the biotechnological landscape.